Log In
Print
BCIQ
Print
Print this Print this
 

LE-MPP, Loteprednol etabonate mucosal penetrating particle (KPI-121)

  Manage Alerts
Collapse Summary General Information
Company Kala Pharmaceuticals Inc.
DescriptionLoteprednol etabonate, a steroid, delivered using mucus-penetrating nanoparticles
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today